Notes to Condensed Consolidated Financial Statements
For the three months and nine months ended September
30, 2021 and 2020
(Unaudited)
Note
1 – Business Organization, Nature of Operations
Movano Inc. (the “Company” or “Movano”
or “Our”) was incorporated in Delaware on January 30, 2018 as Maestro Sensors Inc. and changed its name to Movano Inc.
on August 3, 2018. The Company is in the development-stage and is a health-focused technology company creating simple, smart, and
personalized devices designed to help individuals on their health journey optimize for good health today and to help prevent and manage
chronic diseases in the future. The Company’s devices are being developed to provide vital health information, including glucose
and blood pressure data, in a variety of form factors to meet individual style needs and give users actionable feedback to improve the
quality of their life.
On April 28, 2021, the Company established
Movano Ireland Limited, organized under the laws of Ireland, as a wholly owned subsidiary of the Company. Operations and activity at the
wholly owned subsidiary were not significant for the three and nine months ended September 30, 2021.
Since inception, the Company has engaged in only
limited research and development of product candidates and underlying technology. As of December 31, 2020, the Company had not yet
completed the development of its product and had not yet recorded any revenues. From February 2020 to December 2020, the Company
issued subordinated convertible promissory notes for approximately $11.1 million in net proceeds (See Note 8). Additionally,
in May 2020, the Company received a Paycheck Protection Program loan for $0.4 million (See Note 7).
In December 2019, a novel coronavirus and
the resulting disease (“COVID-19”) was reported, and in January 2020, the World Health Organization (“WHO”)
declared it a Public Health Emergency of International Concern. In February 2020, the WHO raised its assessment of the COVID-19 threat
from high to very high at a global level due to the continued increase in the number of cases and affected countries, and in March 2020,
the WHO characterized COVID-19 as a pandemic. The Company is continuing to ascertain the long-term impact of the COVID-19 pandemic on
its business, but given the uncertainty about the situation, the Company cannot estimate the impact to its financial statements from the
economic crisis arising from COVID-19.
The Company’s Registration Statement on
Form S-1, as amended (Reg. No. 333-252671), was declared effective by the U.S. Securities and Exchange Commission (the “SEC”)
on March 23, 2021. The registration statement registered the securities offered in the Company’s initial public offering (“IPO”).
In the IPO, the Company sold 9,775,000 shares of common stock at a price to the public of $5.00 per share, including the full exercise
of the underwriters’ option to purchase additional shares. The IPO closed on March 25, 2021 and the underwriters exercised
their overallotment option as of March 25, 2021, as a result of which the Company raised net proceeds of $44.3 million after
deducting $3.3 million in underwriting discounts, commissions, and expenses and $1.3 million in offering expenses paid or payable
by the Company. National Securities Corporation (“NSC”) was the underwriter for the IPO, and also received a warrant related
to the IPO, which is discussed in Note 11. No portion of the net proceeds from the IPO were used for payments made by the Company
to its directors or officers or persons owning ten percent or more of its common stock or to their associates, or to the Company’s
affiliates, other than payments in the ordinary course of business to officers for salaries and to nonemployee directors as compensation
for board or board committee service.
The Company has incurred losses from operations
and has generated negative cash flows from operating activities since inception. The Company expects to continue to incur net losses for
the foreseeable future as it continues the development of its technology. The Company’s ultimate success depends on the outcome
of its research and development and commercialization activities, for which it expects to incur additional losses in the future. Through
September 30, 2021, the Company has relied primarily on the proceeds from equity offerings to finance its operations. The Company
expects to require additional financing to fund its future planned operations, including research and development and commercialization
of its products. The Company will likely raise additional capital through the issuance of equity, borrowings, or strategic alliances with
partner companies. However, if such financing is not available at adequate levels, the Company would need to reevaluate its operating
plans.
Movano Inc.
Notes to Condensed Consolidated Financial Statements
For the three months and nine months ended September
30, 2021 and 2020
(Unaudited)
Note
2 – Summary of Significant Accounting Policies
Basis of Presentation
The accompanying unaudited condensed consolidated
financial statements include the accounts of the Company and its wholly owned subsidiary and have been prepared in accordance with U.S.
generally accepted accounting principles (GAAP) for interim financial information and in accordance with the instructions to Form 10-Q
and Rule 10-01 of Regulation S-X. Accordingly, they do not include all the information and footnotes required by GAAP for complete
financial statements. The unaudited condensed consolidated financial statements have been prepared on the same basis as the annual financial
statements. In the opinion of management, the accompanying unaudited condensed consolidated financial statements reflect all adjustments
(consisting only of normal recurring adjustments) considered necessary for a fair presentation. Intercompany transactions are eliminated
in the condensed consolidated financial statements. The results of operations for the three and nine months ended September 30,
2021 are not necessarily indicative of the results to be expected for the year ending December 31, 2021. The condensed consolidated
balance sheet as of December 31, 2020 has been derived from audited financial statements at that date but does not include all the
information required by GAAP for complete financial statements. These condensed consolidated financial statements should be read in conjunction
with the audited financial statements and notes thereto for the preceding fiscal year included in Amendment No. 2 to the Company’s
Registration Statement on Form S-1 filed with the SEC on March 17, 2021.
Reclassification
Certain reclassifications have been made to
prior periods’ condensed consolidated financial statements to conform to the current period presentation. These
reclassifications did not result in any change in previously reported net loss, total assets or stockholders’ equity
(deficit).
Use of Estimates
The preparation of financial statements in conformity
with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure
of contingent assets and liabilities at the date of the financial statements, and the reported amounts of expenses during the reporting
periods.
Significant estimates and assumptions reflected
in these condensed consolidated financial statements include, but are not limited to, the accrual of research and development expenses,
the valuation of common stock, stock options and warrants, the valuation of the embedded redemption derivative liability and income taxes.
Estimates are periodically reviewed considering changes in circumstances, facts, and experience. Changes in estimates are recorded in
the period in which they become known. Actual results could differ from those estimates or assumptions.
Segment Information
Operating segments are defined as components of
an enterprise about which separate discrete information is available for evaluation by the chief operating decision maker, or decision-making
group, in deciding how to allocate resources and in assessing performance. The Company views its operations and manages its business in
one segment. The Company’s chief operating decision maker is the chief executive officer.
Cash, Cash Equivalents and Short-term Investments
The Company invests its excess cash primarily
in money market funds, commercial paper and short-term debt securities. The Company considers all highly liquid investments with an original
maturity of three months or less to be cash equivalents. The Company classifies all marketable securities for use in current operations,
even if the security matures beyond 12 months, and presents them as short-term investments in the condensed consolidated balance
sheets.
Movano Inc.
Notes to Condensed Consolidated Financial Statements
For the three months and nine months ended September
30, 2021 and 2020
(Unaudited)
The Company determines the appropriate classification
of marketable securities at the time of purchase and reevaluates such designation at each balance sheet date. The Company has classified
and accounted for the purchased marketable securities as available-for-sale. After considering the Company’s capital preservation
objectives, as well as its liquidity requirements, the Company may sell securities prior to their stated maturities. The Company carries
its available-for-sale short-term investments at fair value. The Company reports the unrealized gains and losses, net of taxes, as a component
of stockholders’ equity, except for unrealized losses determined to be credit-related, which are recorded as other income (expense),
net in the condensed consolidated statements of operations and comprehensive loss and reports an allowance for credit losses in short-term
investments on the balance sheet, if any. The Company determines any realized gains or losses on the sale of short-term investments on
a specific identification method and records such gains and losses as a component of other income (expense), net. Interest earned on cash,
cash equivalents, and short-term investments is recorded in interest and other income, net in the accompanying condensed consolidated
statements of operations and comprehensive loss and was insignificant during the three and nine months ended September 30, 2021 or
2020.
The Company's investment policy only allows purchases
of high credit quality instruments and provides guidelines on concentrations and credit quality to ensure minimum risk of loss. The Company
evaluates whether the unrealized loss on available-for-sale short-term investments is the result of the credit worthiness of the securities
it held, or other non-credit-related factors such as liquidity by reviewing a number of factors such as the implied yield of the corporate
note based on the market price, the nature of the invested entity's business or industry, market capitalization relative to debt, changes
in credit ratings, and the market prices of the instruments subsequent to the period end.
Concentrations of Credit Risk and Off-Balance
Sheet Risk
Cash and cash equivalents are financial instruments
that are potentially subject to concentrations of credit risk. All cash and cash equivalents are held in United States financial institutions.
Cash equivalents consist of interest-bearing money market accounts. The amounts deposited in the money market accounts exceed federally
insured limits. The Company has not experienced any losses related to this account and believes the associated credit risk to be minimal
due to the financial condition of the depository institutions in which those deposits are held.
The Company has no financial instruments with
off-balance sheet risk of loss.
Prepaid Expenses and Other Current Assets
Prepaid expenses and other current assets were
comprised of prepaid expenses, other current receivables, and deferred offering costs, which consist of legal, accounting, filing and
other fees related to the IPO that were capitalized prior to the IPO. The deferred offering costs were offset against proceeds from the
IPO within additional paid-in capital upon the effective date of the IPO. As of September 30, 2021 and December 31, 2020, offering
costs of approximately $0 and $0.5 million were capitalized, respectively.
Paycheck Protection Program Loan
The Company accounted for funds received from
the Paycheck Protection Program as a financial liability with interest accrued and expensed over the term of the loan under the effective
interest method. The loan remained recorded as a liability until the Company was legally released from the liability. The amount that
was ultimately forgiven by the lender was recognized in the condensed consolidated statement of operations and comprehensive loss as a
gain on extinguishment.
Convertible Financial Instruments
The Company bifurcates embedded redemption and
conversion options from their host instruments and accounts for them as freestanding derivative financial instruments at fair value if
certain criteria are met. The criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative
instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument
that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under otherwise applicable
GAAP with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative
instrument would be considered a derivative instrument. Debt discounts under these arrangements are amortized to interest expense using
the interest method over the earlier of the term of the related debt or their earliest date of redemption.
Movano Inc.
Notes to Condensed Consolidated Financial Statements
For the three months and nine months ended September
30, 2021 and 2020
(Unaudited)
From time to time, the Company issues convertible
financial instruments to nonemployees in payment for services that are provided. Until the services are completely rendered, the Company
will expense the principal and any interest earned prior to the service completion to the representative expense account for the services
performed and will record a noncurrent liability for the expected amount of the principal balance. Upon completion of the services, the
Company will reclassify the noncurrent liability balance to the balance of an outstanding convertible financial instrument and assess
the embedded redemption and conversion options that are applicable at that time.
Beneficial Conversion Feature
If the conversion feature of conventional convertible
promissory notes provides for a rate of conversion that is below fair value, this feature is characterized as a beneficial conversion
feature (“BCF”). A BCF is recorded by the Company as a debt discount and as additional paid-in capital on the condensed consolidated
balance sheet. In those circumstances, the convertible debt is recorded net of the discount related to the BCF and the Company amortizes
the discount to interest expense over the life of the debt using the effective interest method.
Redeemable Convertible Preferred Stock
The Company records all shares of redeemable convertible
preferred stock at their respective issuance price less issuance costs on the dates of issuance. Under certain circumstances the Company
would have been required to redeem the Series A and Series B redeemable convertible preferred stock unless an IPO had been consummated
prior to April 1, 2021, or an extension or waiver was obtained upon approval of a majority of the holders of such preferred stock.
As the preferred stock became redeemable due to the passage of time, the Company considered the preferred stock to be redeemable as of
April 1, 2021. The Company records the accretion of the Series A and B preferred stock balances to their respective redemption amounts
using the effective interest method. The redeemable convertible preferred stock is presented outside of stockholders’ deficit on
the condensed consolidated balance sheet as of December 31, 2020. Upon the IPO, the redeemable convertible preferred stock converted
in to 11,436,956 shares of common stock.
Income Taxes
The Company accounts for income taxes using the
asset and liability method. Under this method, deferred tax assets and liabilities are determined based on differences between the financial
statement and tax basis of assets and liabilities and net operating loss and credit carryforwards using enacted tax rates in effect for
the year in which the differences are expected to reverse. Valuation allowances are established when necessary to reduce deferred tax
assets to the amounts expected to be realized. As the Company maintained a full valuation allowance against its deferred tax assets, the
changes resulted in no provision or benefit from income taxes during the three and nine months ended September 30, 2021 and 2020.
The Company accounts for unrecognized tax benefits
using a more-likely-than-not threshold for financial statement recognition and measurement of tax positions taken or expected to be taken
in a tax return. The Company establishes a liability for tax-related uncertainties based on estimates of whether, and the extent to which,
additional taxes will be due. The Company records an income tax liability, if any, for the difference between the benefit recognized and
measured and the tax position taken or expected to be taken on the Company’s tax returns. To the extent that the assessment of such
tax positions changes, the change in estimate is recorded in the period in which the determination is made. The liability is adjusted
considering changing facts and circumstances, such as the outcome of a tax audit. The provision for income taxes includes the impact of
liability provisions and changes to the liability that are considered appropriate. Changes in recognition or measurement are reflected
in the period in which the change in judgment occurs.
For interim periods, the Company estimates its
annual effective income tax rate and applies the estimated rate to the year-to-date income or loss before income taxes. The Company computes
the tax provision or benefit related to items reported separately and recognizes the items net of their related tax effect in the interim
periods in which they occur. The Company recognizes the effect of changes in enacted tax laws or rates in the interim periods in which
the changes occur.
Movano Inc.
Notes to Condensed Consolidated Financial Statements
For the three months and nine months ended September
30, 2021 and 2020
(Unaudited)
Stock-Based Compensation
The Company measures equity classified stock-based
awards granted to employees, directors, and nonemployees based on the estimated fair value on the date of grant and recognizes compensation
expense of those awards on a straight-line basis over the requisite service period, which is generally the vesting period of the respective
award. The fair value of each stock option grant is estimated on the date of grant using the Black-Scholes option pricing model. This
valuation model for stock-based compensation expense requires the Company to make assumptions and judgments about the variables used in
the calculation including the expected term, the volatility of the Company’s common stock, and an assumed risk-free interest rate.
The Company accounts for forfeitures as they occur.
Early Exercised Stock Option Liability
Upon the early exercise of stock options by employees,
the Company records as a liability the purchase price of unvested common stock that the Company has a right to repurchase if and when
the employment of the stockholder terminates before the end of the requisite service period. The proceeds originally recorded as a liability
are reclassified to additional paid-in capital as the Company’s repurchase right lapses.
Net Loss per Share Attributable to Common
Stockholders
Basic net loss per share attributable to common
stockholders is calculated by dividing the net loss attributable to common stockholders by the weighted average number of shares of common
stock outstanding during the period, without consideration for common stock equivalents. The net loss attributable to common stockholders
is calculated by adjusting the net loss of the Company for the accretion on the Series A and B redeemable convertible preferred stock
and cumulative dividends on Series A and B redeemable convertible preferred stock. Diluted net loss per share attributable to common
stockholders is the same as basic net loss per share attributable to common stockholders, since the effects of potentially dilutive securities
are antidilutive.
Recently Adopted Accounting Pronouncements
In December 2019, the FASB issued Accounting
Standards Update 2019-12, Income Taxes (Topic 740). The amendments in this update provide further simplification of accounting
standards for the accounting for income taxes. Certain exceptions for requirements regarding the accounting for franchise taxes, tax basis
of goodwill, and tax law rate changes are made. The Company early adopted this guidance as of January 1, 2021 and the adoption did
not have a significant impact on the condensed consolidated financial statements and related disclosures.
In June 2016, the FASB issued ASU 2016-13,
Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, as amended,
which requires the early recognition of credit losses on financing receivables and other financial assets in scope. ASU 2016-13 requires
the use of a transition model that will result in the earlier recognition of allowances for losses. The Company early adopted this guidance
as of January 1, 2021 and the adoption did not have a significant impact on the condensed consolidated financial statements and related
disclosures.
Note
3 – FAIR VALUE MEASUREMENTS
Financial assets and liabilities are recorded
at fair value. The Company uses a three-level hierarchy, which prioritizes, within the measurement of fair value, the use of market-based
information over entity-specific information for fair value measurements based on the nature of inputs used in the valuation of an asset
or liability as of the measurement date. Fair value focuses on an exit price and is defined as the price that would be received to sell
an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The inputs or
methodology used for valuing financial instruments are not necessarily an indication of the risk associated with investing in those financial
instruments.
Movano Inc.
Notes to Condensed Consolidated Financial Statements
For the three months and nine months ended September
30, 2021 and 2020
(Unaudited)
A three-tier fair value hierarchy is used to prioritize
the inputs in measuring fair value as follows:
|
Level 1 –
|
Quoted prices in active markets for identical assets or liabilities.
|
|
Level 2 –
|
Quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable, either directly or indirectly.
|
|
Level 3 –
|
Significant unobservable inputs that cannot be corroborated by market data.
|
The Company measures its cash equivalents, short-term
investments and derivative financial instruments at fair value. The Company classifies its cash equivalents and short-term investments
within Level 1 or Level 2 because the Company values these investments using quoted market prices or alternative pricing sources
and models utilizing market observable inputs. The fair value of the Company’s Level 1 financial assets is based on quoted
market prices of the identical underlying security. The fair value of the Company’s Level 2 financial assets is based on inputs
that are directly or indirectly observable in the market, including the readily-available pricing sources for the identical underlying
security that may not be actively traded.
The asset’s or liability’s fair value
measurement level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement.
Changes in fair value measurements categorized
within Level 3 of the fair value hierarchy are analyzed each period based on changes in estimates or assumptions and recorded as
appropriate. At December 31, 2020, the warrants related to the Series A preferred stock issuance, the Series B preferred
stock issuance, and the convertible promissory notes and the derivative liability related to the issuance of convertible promissory notes
are classified within level 3 of the valuation hierarchy. The instruments are not present at September 30, 2021 in light of
accounting ramifications of the IPO, which are discussed further in Note 8 and Note 11.
The carrying amounts of prepaid expenses, payroll
tax credit, accounts payable and accrued liabilities approximate fair value due to the short-term nature of these instruments.
Based upon interest rates currently available
to the Company for debt with similar terms, the carrying values of the Company’s convertible promissory notes and Paycheck Protection
Program Loan are approximately equal to their fair values.
The following tables provide a summary of the
assets and liabilities that are measured at fair value on a recurring basis as of September 30, 2021 and December 31, 2020
(in thousands).
|
|
September 30, 2021
|
|
|
|
Fair Value
|
|
|
Level 1
|
|
|
Level 2
|
|
|
Level 3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash equivalents:
|
|
|
|
|
|
|
|
|
|
|
|
|
Money market funds
|
|
$
|
10,156
|
|
|
$
|
10,156
|
|
|
$
|
—
|
|
|
$
|
—
|
|
Commercial paper
|
|
|
6,409
|
|
|
|
—
|
|
|
|
6,409
|
|
|
|
—
|
|
Total cash equivalents
|
|
$
|
16,565
|
|
|
$
|
10,156
|
|
|
$
|
6,409
|
|
|
$
|
—
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Short-term investments:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Certificates of deposit
|
|
$
|
250
|
|
|
$
|
—
|
|
|
$
|
250
|
|
|
$
|
—
|
|
Commercial paper
|
|
|
6,199
|
|
|
|
—
|
|
|
|
6,199
|
|
|
|
—
|
|
Corporate notes
|
|
|
13,468
|
|
|
|
—
|
|
|
|
13,468
|
|
|
|
—
|
|
Municipal bonds
|
|
|
2,252
|
|
|
|
—
|
|
|
|
2,252
|
|
|
|
—
|
|
Total short-term investments
|
|
$
|
22,169
|
|
|
$
|
—
|
|
|
$
|
22,169
|
|
|
$
|
—
|
|
|
|
December 31, 2020
|
|
|
|
Fair Value
|
|
|
Level 1
|
|
|
Level 2
|
|
|
Level 3
|
|
Cash equivalents – money market funds
|
|
$
|
5,181
|
|
|
$
|
5,181
|
|
|
$
|
—
|
|
|
$
|
—
|
|
Warrant liability
|
|
$
|
1,549
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
1,549
|
|
Derivative liability
|
|
$
|
121
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
121
|
|
Movano Inc.
Notes to Condensed Consolidated Financial Statements
For the three months and nine months ended September
30, 2021 and 2020
(Unaudited)
Note
4 – CASH, CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS
Cash, cash equivalents and short-term investments
consist of the following (in thousands):
|
|
September 30,
|
|
|
December 31,
|
|
|
|
2021
|
|
|
2020
|
|
Cash and cash equivalents:
|
|
|
|
|
|
|
Cash
|
|
$
|
568
|
|
|
$
|
529
|
|
Money market funds
|
|
|
10,156
|
|
|
|
5,181
|
|
Commercial paper
|
|
|
6,409
|
|
|
|
—
|
|
Total cash and cash equivalents
|
|
$
|
17,133
|
|
|
$
|
5,710
|
|
|
|
|
|
|
|
|
|
|
Short-term investments:
|
|
|
|
|
|
|
|
|
Certificates of deposit
|
|
$
|
250
|
|
|
$
|
—
|
|
Commercial paper
|
|
|
6,199
|
|
|
|
—
|
|
Corporate notes
|
|
|
13,468
|
|
|
|
—
|
|
Municipal bonds
|
|
|
2,252
|
|
|
|
—
|
|
Total short-term investments
|
|
$
|
22,169
|
|
|
$
|
—
|
|
The contractual maturities of short-term investments
classified as available-for-sale as of September 30, 2021 were as follows (in thousands):
|
|
September 30,
|
|
|
|
2021
|
|
|
|
|
|
Due within one year
|
|
$
|
21,329
|
|
Due after one year through five years
|
|
|
840
|
|
Total
|
|
$
|
22,169
|
|
The following table summarizes the unrealized
gains and losses related to short-term investments classified as available-for-sale on the Company’s condensed consolidated balance
sheet (in thousands):
|
|
September 30, 2021
|
|
|
|
Amortized
Cost
|
|
|
Gross Unrealized Gains
|
|
|
Gross Unrealized Losses
|
|
|
Aggregate Estimated Fair Value
|
|
Short-term investments:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Certificates of deposit
|
|
$
|
250
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
250
|
|
Commercial paper
|
|
|
6,199
|
|
|
|
—
|
|
|
|
—
|
|
|
|
6,199
|
|
Corporate notes
|
|
|
13,471
|
|
|
|
1
|
|
|
|
(4
|
)
|
|
|
13,468
|
|
Municipal bonds
|
|
|
2,252
|
|
|
|
—
|
|
|
|
—
|
|
|
|
2,252
|
|
Total short-term investments
|
|
$
|
22,172
|
|
|
$
|
1
|
|
|
$
|
(4
|
)
|
|
$
|
22,169
|
|
As of September 30, 2021, the gross unrealized
loss on available-for-sale short-term investments was immaterial and there were no expected credit losses related to the Company's available-for-sale
debt securities. The Company has determined that all unrealized losses are temporary. As of September 30, 2021, no allowance for
credit losses in short-term investments was recorded.
No sales of available-for-sale short-term investments occurred during
the three and nine months ended September 30, 2021.
Movano Inc.
Notes to Condensed Consolidated Financial Statements
For the three months and nine months ended September
30, 2021 and 2020
(Unaudited)
Note
5 – Property and Equipment
Property and equipment, net, as of September 30,
2021 and December 31, 2020, consisted of the following (in thousands):
|
|
September 30,
|
|
|
December 31,
|
|
|
|
2021
|
|
|
2020
|
|
Office equipment and furniture
|
|
$
|
218
|
|
|
$
|
43
|
|
Software
|
|
|
115
|
|
|
|
—
|
|
Test equipment
|
|
|
234
|
|
|
|
22
|
|
Total property and equipment
|
|
|
567
|
|
|
|
65
|
|
Less: accumulated depreciation
|
|
|
(67
|
)
|
|
|
(27
|
)
|
Total property and equipment, net
|
|
$
|
500
|
|
|
$
|
38
|
|
Total depreciation and amortization expense related
to property and equipment for the three and nine months ended September 30, 2021 was approximately $22,000 and $40,000, respectively.
Total depreciation expense related to property and equipment for the three and nine months ended September 30, 2020 was approximately
$4,000 and $10,000, respectively.
Note
6 – Other Current Liabilities
Other current liabilities as of September 30,
2021 and December 31, 2020 consisted of the following (in thousands):
|
|
September 30,
|
|
|
December 31,
|
|
|
|
2021
|
|
|
2020
|
|
Accrued research and development
|
|
$
|
417
|
|
|
$
|
197
|
|
Accrued compensation
|
|
|
1,530
|
|
|
|
184
|
|
Accrued vacation
|
|
|
260
|
|
|
|
192
|
|
Accrued legal expense
|
|
|
1
|
|
|
|
41
|
|
Accrued accounting and consulting expense
|
|
|
16
|
|
|
|
40
|
|
Other
|
|
|
64
|
|
|
|
12
|
|
|
|
$
|
2,288
|
|
|
$
|
666
|
|
Movano Inc.
Notes to Condensed Consolidated Financial Statements
For the three months and nine months ended September
30, 2021 and 2020
(Unaudited)
NOTE
7 – PAYCHECK PROTECTION PROGRAM LOAN
The Paycheck Protection Program (“PPP”)
was established under the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”) and is administered by the
U.S. Small Business Administration (“SBA”). On April 23, 2020, the Company entered into a promissory note with Silicon
Valley Bank evidencing an unsecured loan in the aggregate amount of approximately $351,000 under the PPP (the “PPP Loan”).
The interest rate on the PPP Loan was 1.00% and the term was two years, with a deferral of payments for ten months from the date of origination.
On May 7, 2020, the Company elected to repay the PPP loan in full until further guidance was provided by the SBA on the loan origination
and eligibility requirements. On May 27, 2020, the Company entered into a promissory note with Silicon Valley Bank evidencing an
unsecured loan in the aggregate amount of approximately $351,000, with all other terms the same as the prior loan. Beginning eleven months
from the date of the PPP Loan, the Company was required to make monthly payments of principal and interest. The promissory note evidencing
the PPP Loan contained customary events of default relating to, among other things, payment defaults or breaching the terms of the PPP
Loan documents. The occurrence of an event of default may result in the repayment of all amounts outstanding, collection of all amounts
owing from the Company, or filing suit and obtaining judgment against the Company. The PPP Loan was repayable at any time by the Company
without prepayment penalties.
Funds from the PPP Loan could be used for payroll
costs, costs used to continue group health care benefits, mortgage payments, rent, utilities, and interest on other debt obligations,
if those debt obligations were incurred before February 15, 2020. The Company used the entire PPP Loan amount for qualifying expenses.
Under the terms of the CARES Act, PPP loan recipients
can apply for and be granted forgiveness for all or a portion of the loan granted under the PPP. Such forgiveness will be determined,
subject to limitations, based on the use of loan proceeds for qualifying expenses. On May 28, 2021, the Company received full loan
forgiveness for obligations related to the PPP loan. The Company accounted for the PPP loan as debt, and the loan forgiveness
was accounted for as a debt extinguishment. The amount of loan and interest forgiven is recognized as a gain upon debt extinguishment
and is reported in the accompanying condensed consolidated statement of operations and comprehensive loss for the three months and nine
months ended September 30, 2021.
NOTE
8 – CONVERTIBLE PROMISSORY NOTES
On various dates between February 2020 and
December 2020, the Company received total proceeds of approximately $11.8 million from the issuance of subordinated convertible
promissory notes (“Convertible Notes”) to investors. The Convertible Notes accrued interest at 4% per year and the principal
balance of the Convertible Notes, plus all accrued interest would have been due on February 28, 2022 (the Maturity Date).
Movano Inc.
Notes to Condensed Consolidated Financial Statements
For the three months and nine months ended September
30, 2021 and 2020
(Unaudited)
The Convertible Notes were convertible upon the
occurrence of certain events, including upon a change in control or a next equity financing. The conversion features are described as
follows:
Conversion Event
|
|
Description
|
|
Conversion Price
|
Automatic Conversion – Next Qualified Equity Financing
|
|
Upon the closing of a Next Qualified Equity Financing (defined as greater than $5,000,000), the Convertible Notes are converted into shares issued equal to the outstanding balance divided by the Conversion Price.
|
|
An amount equal to the lower of (i) 80% of the lowest per-share selling price of such stock sold by the Company at the Next Qualified Equity Financing or (ii) the implied per share price determined by dividing $60,000,000 by the total number of Common Stock Equivalents (defined as fully diluted common shares for all outstanding securities, excluding common shares reserved for issuance or exercise of options or grants in the future) immediately prior to Next Qualified Equity Financing closing.
|
|
|
|
|
|
Automatic Conversion – Change of Control (defined as consolidation or merger of the Company or transfer of a majority of share ownership or disposition of substantially all assets of the Company)
|
|
If at any time before payment or conversion of the balance, the Company effects a Change of Control, all of the balance outstanding immediately prior to such Change of Control will automatically convert into the most senior series of Preferred Stock outstanding immediately prior to such Change of Control at the Conversion Price.
|
|
An amount equal to the implied per share price determined by dividing $60,000,000 by the total number of Common Stock Equivalents immediately prior to such Change of Control.
|
|
|
|
|
|
Automatic Conversion – Maturity Date
|
|
If the Company has not paid or otherwise converted the entire balance before the Maturity Date, then on the Maturity Date, all of the balance then outstanding will automatically convert into the most senior series of Preferred Stock outstanding as of the Maturity Date at the Conversion Price then in effect.
|
|
An amount equal to the implied per share price determined by dividing $60,000,000 by the total number of Common Stock Equivalents as of the Maturity Date.
|
|
|
|
|
|
Automatic Conversion – IPO
|
|
If at any time before payment or conversion of the balance, the Company consummates an IPO, all of the balance outstanding immediately prior to the IPO will automatically convert into Common Stock at the Conversion Price.
|
|
An amount equal to the lower of (i) 80% of the lowest per-share selling price of the Common Stock sold by the Company in an IPO or (ii) the implied per share price determined by dividing $60,000,000 by the total number of Common Stock Equivalents immediately prior to closing of an IPO.
|
Movano Inc.
Notes to Condensed Consolidated Financial Statements
For the three months and nine months ended September
30, 2021 and 2020
(Unaudited)
Conversion Event
|
|
Description
|
|
Conversion Price
|
Optional Conversion
|
|
If at any time while the Convertible Notes are still outstanding the Company sells stock in a single transaction or in a series of related transactions that does not constitute a Next Qualified Equity Financing (and thus is defined as a Non-qualified Financing), then, at the closing of the Nonqualified Financing, the balance then outstanding may be converted, at the option of the holder, into that number of shares of Non-qualified Preferred Stock (preferred stock sold in the Non-qualified Financing) determined by dividing (i) the balance by (ii) the Conversion Price then in effect.
|
|
An amount equal to the lowest per share selling price of Nonqualified Preferred Stock sold by the Company for new cash investment in the Non-Qualified Financing.
|
As part of the Convertible Note financing, the
Company agreed to issue subordinated convertible promissory notes to nonemployees in exchange for services totaling $747,000.
As of December 31, 2020, Convertible Notes
totaling approximately $247,000 were issued to nonemployees in exchange for services. As of December 31, 2020, future services
of $500,000 of the original $747,000 had not been fully completed. A portion of those services that had been completed were recorded as
a component of other noncurrent liabilities of $150,000 on the condensed consolidated balance sheet at December 31, 2020.
During the three months ended March 31, 2021,
additional nonemployee services of $50,000 were completed, which were recorded as a component of other noncurrent liabilities. In connection
with the IPO, a Convertible Note for $500,000 was issued for nonemployee services and the $300,000 of the nonemployee services that remained
to be completed was recorded in prepaid assets and other current expenses on the condensed consolidated balance sheet. The Company calculated
a BCF of approximately $500,000 upon the issuance of this Convertible Note. During the three and nine months ended September 30,
2020, nonemployee services of services of $260,000 and $310,000 were completed.
In connection with the Convertible Notes, the
Company issued 10,000 and 204,500 warrants to purchase common stock, to a noteholder and its brokers, respectively. The warrants have
a five-year life and are initially exercisable into common stock at $2.97 per share. (See Note 11 – Common Stock Warrants for fair
value computation and discussion of the change in the exercise price). During March 2021, 42,220 of these warrants to purchase common
stock were cancelled.
Issuance costs and commissions to brokers to obtain
the Convertible Notes were recorded as a debt discount in the amount of approximately $83,000 and $612,000, respectively.
The Company determined that the terms that would
result in Convertible Notes automatically converting at (i) 80% of the lowest per-share selling price of the stock sold by the Company
in the Next Qualified Equity Financing or (ii) 80% of the lowest per-share selling price of the Conversion Stock sold by the Company in
an IPO are deemed a redemption feature. The Company also concluded that those redemption features require bifurcation from the Convertible
Notes and subsequent accounting in the same manner as a freestanding derivative. Accordingly, subsequent changes in the fair value of
these redemption features are measured at each reporting period and recognized in the condensed consolidated statement of operations and
comprehensive loss.
The sum of the fair value of the warrants, the
fair value of the embedded redemption derivative liability, issuance costs, BCF and commission payments for the Convertible Notes were
recorded as debt discounts to be amortized to interest expense over the respective term using the effective interest method. During the
three and nine months ended September 30, 2021, the Company recognized interest expense of approximately $0 and $0.8 million from
the accretion of those debt discounts, respectively. During the three and nine months ended September 30, 2020, the Company recognized
interest expense of approximately $0.3 million and $0.4 million, respectively, from the accretion of those debt discounts.
Movano Inc.
Notes to Condensed Consolidated Financial Statements
For the three months and nine months ended September
30, 2021 and 2020
(Unaudited)
The Convertible Notes automatically converted
upon the closing of the IPO at the implied per share price determined by dividing $60,000,000 by the total number of Common Stock Equivalents
immediately prior to the closing of the IPO. The outstanding principal ($12.5 million) and interest due ($0.4 million) under
the Convertible Notes, in an aggregate amount of $12.9 million, was converted into 5,015,494 shares of the Company’s common
stock at the implied per share conversion of $2.5736. The carrying value of the Convertible Notes was credited to common stock and additional
paid-in capital on the condensed consolidated balance sheet. The remaining unamortized discount of $0.4 million was recorded to additional
paid-in capital and no gain or loss was recognized on the conversion. The remaining unamortized discount related to the BCF of $0.5 million
was recognized immediately as interest expense in the condensed consolidated statement of operations and comprehensive loss.
Derivative Liability
As described above, the redemption provisions
embedded in the Convertible Notes required bifurcation and measurement at fair value as a derivative. The fair value of the Convertible
Note embedded redemption derivative liability was calculated by determining the value of the debt component of the Convertible Notes at
various conversion or maturity dates using a Probability Weighted Expected Return valuation method. The fair value calculation placed
greater probability on the occurrence of the conversion or the maturity date scenario, with little or no weight given to other scenarios.
The fair value of the embedded redemption derivative liability is significantly influenced by the discount rate, the remaining term to
maturity and the Company’s assumptions related to the probability of a qualified financing or no financing prior to maturity. The
Financing Date is the estimated date of an automatic conversion as the result of a Next Qualified Equity Financing or an IPO.
The Company estimated the fair value of the embedded
redemption derivative liability using the following weighed average assumptions as of December 31, 2020:
|
|
Financing Date
|
|
Maturity Date
|
Probability of Conversion at Financing
|
|
80%
|
|
20%
|
Expected Term
|
|
March 2021
|
|
February 2022
|
Conversion Ratio
|
|
1.25
|
|
N/A
|
Discount Rate
|
|
1.68% to 11.67%
|
|
N/A
|
The Company estimated the fair value of the embedded
redemption derivative liability using the following weighed average assumptions as of September 30, 2020:
|
|
Financing Date
|
|
Maturity Date
|
Probability of Conversion at Financing
|
|
80%
|
|
20%
|
Expected Term
|
|
March 2021
|
|
February 2022
|
Conversion Ratio
|
|
1.25
|
|
N/A
|
Discount Rate
|
|
5.19% to 11.67%
|
|
N/A
|
The embedded redemption derivative liability no
longer had significant value as of the date of the Company’s IPO since the conversion of the Convertible Notes occurred via a redemption
feature that was not bifurcated as a derivative. Upon the conversion of the Convertible Notes at the IPO, the Company recorded a final
change in the fair value of the derivative liability of $0.1 million in the condensed consolidated statement of operations and comprehensive
loss, and the derivative liability was extinguished.
Movano Inc.
Notes to Condensed Consolidated Financial Statements
For the three months and nine months ended September
30, 2021 and 2020
(Unaudited)
The changes in the fair value of the derivative
liability for the nine months ended September 30, 2021 and for the three and nine months ended September 30, 2020 were as follows:
|
|
December 31,
2020
|
|
|
Fair Value at
issuance date
|
|
|
Change in
fair value
|
|
|
September 30,
2021
|
|
Derivative liability
|
|
$
|
121
|
|
|
|
—
|
|
|
|
(121
|
)
|
|
$
|
—
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
June 30,
2020
|
|
|
|
Fair Value at
issuance date
|
|
|
|
Change in
fair value
|
|
|
|
September 30,
2020
|
|
Derivative liability
|
|
$
|
453
|
|
|
|
164
|
|
|
|
(220
|
)
|
|
$
|
397
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31,
2019
|
|
|
|
Fair Value at
issuance date
|
|
|
|
Change in
fair value
|
|
|
|
September 30,
2020
|
|
Derivative liability
|
|
$
|
—
|
|
|
|
751
|
|
|
|
(354
|
)
|
|
$
|
397
|
|
Note
9 – REDEEMABLE Convertible Preferred Stock
On March 28, 2019, the Company’s Second
Amended and Restated Certificate of Incorporation was filed with the Delaware Secretary of State which (i) increased the number of shares
of common stock the Company is authorized to issue to 22,069,652; (ii) increased the number of shares of preferred stock the Company was
authorized to issue to 7,930,348, of which 2,692,253 shares were designated as Series A preferred stock and 5,238,095 shares were
designated as Series B preferred stock; (iii) amended and set a fixed conversion price of Series A preferred stock to $1.40;
and (iv) extended the IPO Commitment Date from April 1, 2020 to no later than March 31, 2021.
The Company assessed the accounting treatment
of the amendment of the Certificate of Incorporation related to the Series A preferred stock and determined that the amendment is
a modification for accounting purposes. After considering the nature of the changes as a result of the amendment, the Company determined
the modification of the Series A preferred stock did not have a significant impact on the financial statements.
On various dates from March 2019 through
August 2019, the Company issued 4,942,319 shares of Series B preferred stock at $2.10 per share for net cash proceeds of $9.3 million.
The Series B preferred stock has a liquidation preference of an amount equal to the greater of (i) two times the original issue price
of $2.10 per share (adjusted for stock splits, stock dividends, stock combination, recapitalizations and certain similar events) plus
any declared and unpaid dividends thereon or (ii) the amount per share that would have been received by the holders had the Series B
preferred stock been converted into common stock immediately prior to such liquidation, dissolution or winding-up plus any declared and
unpaid dividends thereon, pari passu with the Series A preferred stock and in preference to any distributions to the holders of common
stock.
The Series B preferred stock was measured
and recorded at the transaction price net of issuance costs, resulting in an initial value of $9.3 million. The accretion to the
carrying value of the Series B preferred stock was recorded as a charge to additional paid in capital. The accumulated accretion as of
the IPO date was $11.5 million, which resulted in an adjusted Series B preferred stock carrying value of $20.8 million.
The accretion to the carrying value of the Series A
preferred stock was recorded as a charge to additional paid-in capital. The accumulated accretion as of the IPO date was $8.2 million,
which resulted in an adjusted Series A preferred stock carrying value of $14.5 million.
Upon the IPO, the redeemable convertible preferred
stock converted in to 11,436,956 shares of common stock and no shares of redeemable convertible preferred stock remain outstanding as
of September 30, 2021.
On March 24, 2021, the Company’s Third
Amended and Restated Certificate of Incorporation was filed with the Delaware Secretary of State which (i) eliminated the Company’s
Series A and Series B preferred stock, (ii) increased the authorized number of shares of common stock to 75,000,000 and (iii)
authorized 5,000,000 shares of preferred stock at par value of $0.0001 per share. The significant rights and preferences of the preferred
stock will be established by the Company’s Board of Directors (the “Board”) upon issuance of any such series of preferred
stock in the future.
Movano Inc.
Notes to Condensed Consolidated Financial Statements
For the three months and nine months ended September
30, 2021 and 2020
(Unaudited)
Note
10 – Common Stock
As of September 30, 2021 and December 31,
2020, the Company was authorized to issue 75,000,000 and 22,069,652 shares of common stock with a par value of $0.0001 per share, and
32,772,060 and 6,393,069 shares were issued and outstanding, respectively.
Conversion of Redeemable Convertible Preferred
Stock
In connection with the closing of the IPO, on
March 25, 2021, the outstanding shares of the Company’s Series A and Series B redeemable convertible preferred stock
were converted into 11,436,956 shares of the Company’s common stock.
Conversion of Convertible Notes
In connection with the funding of the IPO, on
March 25, 2021, the principal and interest due under the Company’s Convertible Notes, in an aggregate amount of $12.9 million,
was converted into 5,015,494 shares of the Company’s common stock.
Third Amended and Restated Certificate of Incorporation
In connection with the IPO, the Third Amended
and Restated Certificate of Incorporation became effective and authorized 75,000,000 shares of common stock at par value of $0.0001 per
share. Dividends may be declared and paid on the common stock when and if determined by the Board of Directors. Upon liquidation, each
common stockholder is entitled to receive an equal portion of the distribution. Each holder of common stock will have one vote in respect
of each share of common stock held. The rights and privileges listed above will be subject to preferential rights of any then outstanding
shares of preferred stock.
At the IPO date, the Company issued 17,000 shares
of common stock for nonemployee services valued at $85,000.
Common stock reserved for future issuance at September 30,
2021 is summarized as follows:
Warrants
to purchase common stock
|
|
|
1,938,143
|
|
Stock options
outstanding
|
|
|
4,877,637
|
|
Stock
options available for future grants
|
|
|
830,322
|
|
Total
|
|
|
7,646,102
|
|
Restricted Stock Purchase Agreements
In 2018, 400,000 shares were issued to the Company’s
founder at inception pursuant to a Restricted Stock Purchase Agreement. The Restricted Stock Purchase Agreement stipulates that in the
event of the voluntary or involuntary termination of the Company’s founder’s continuous service status for any reason (including
death or disability), with or without cause, the Company or its assignees(s) shall have an option (“Repurchase Option”) to
repurchase all or any portion of the shares held by the Purchaser as of the termination date which have not yet been released from the
Company’s Repurchase Option at the original purchase price of $0.0125 per share. Shares are to be released from the Repurchase Option
over four years. The initial 12/48ths of the shares were released on January 30, 2019, and an additional 1/48th of the shares are
being released monthly thereafter. As of September 30, 2021 and December 31, 2020, 33,333 and 108,333 of the shares issued to
the Company’s founder remain subject to the Repurchase Option, respectively. These shares were originally purchased by the Company’s
founder at $0.0125 per share.
In 2018, 3,640,000 shares were also issued pursuant
to a Restricted Stock Purchase Agreement. The holders of these shares are considered related parties of the Company because the holders
are directly related either to the founder or to the legal counsel of the Company. The same terms described above apply to these issuances.
As of September 30, 2021 and December 31, 2020, 303,333 and 985,834 of the shares issued to these holders remain subject to
the Repurchase Option, respectively. These shares were originally purchased by the holders at $0.0125 per share.
Early Exercised Stock Option Liability
During the three and nine months ended September 30,
2021, none and 50,000 shares, respectively, were issued upon the early exercise of common stock options. The Exercise Notice (Early Exercise)
Agreement states that the Company has the option to repurchase all or a portion of the unvested shares in the event of the separation
of the holder from service to the Company. The shares continue to vest in accordance with the original vesting schedules of the former
option agreements. There were no early exercises during the three and nine months ended September 30, 2020.
As of September 30, 2021 and December 31,
2020, the Company has recorded a repurchase liability for approximately $335,000 and $417,000 for 677,085 and 856,814 shares that remain
unvested. The weighted average remaining vesting period is approximately 2.3 years.
Movano Inc.
Notes to Condensed Consolidated Financial Statements
For the three months and nine months ended September
30, 2021 and 2020
(Unaudited)
Note
11 – Common Stock Warrants
Preferred A Placement Warrants
On February 22, 2018, the Company entered
into an agreement with NSC, pursuant to which the Company engaged NSC as the Company’s exclusive financial advisor and placement
agent in connection with an offering or series of offerings of Company securities. Specifically, NSC was the placement agent in connection
with the sale of its Series A preferred stock.
In connection with the closing of Series A preferred
stock offering, the Company issued warrants (“Preferred A Placement Warrants”) to purchase a total of 133,648 shares
of its common stock to NSC on March 14, 2018 and April 23, 2018. On June 1, 2018, the Preferred A Placement Warrants
were reassigned among NSC and three individuals at Liquid Venture Partners (“LVP”). The Preferred A Placement Warrants
have a term of five years and the exercise price is equal to the conversion price of Series A preferred stock upon its conversion.
The Preferred A Placement Warrants included an adjustment provision pursuant to which upon completion of the IPO, and the conversion
of the Series A preferred stock in connection therewith, the number of shares issuable upon exercise of the warrants was adjusted
to be equal to 10% of the aggregate number of common stock shares issued by the Company upon conversion of 1,336,485 shares of Series A
preferred stock (the “Preferred A Adjustment Provision”).
The Second Amended and Restated Certificate of
Incorporation that was approved on March 28, 2019 amended and fixed the conversion price of the Series A preferred stock at $1.40.
As a result, on August 28, 2019, the Company elected to amend and reissue the Preferred A Placement Warrants, thereby reducing
the exercise price to $1.40 and increasing the number of warrant shares by 109,200 to a total of 242,847 warrant shares.
In connection with the IPO, pursuant to the Preferred A
Adjustment Provision variable settlement provision, the number of shares of common stock subject to the Preferred A Placement Warrants
settled, resulting in an additional 50,195 shares of common stock.
Preferred A Lead Investor Warrants
During February 2021, a total of 52,500 warrants
for common stock were issued to advisors to the Company at a weighted average exercise price of $0.0125 per share. The resulting fair
value of the warrants for common stock is not significant.
Preferred B Placement Warrants
On April 16, 2019, in connection with the
Series B preferred stock offering, the Company issued warrants (“Preferred B Placement Warrants”) to purchase 414,270
shares of its common stock to NSC, Newbridge Securities Corporation, and five individuals at LVP. The Preferred B Placement Warrants
have a term of five years and their exercise price is equal to $2.10, the conversion price of Series B preferred stock. The Preferred B
Placement Warrants included an adjustment provision pursuant to which upon completion of the IPO, and the conversion of the Series B
preferred stock in connection therewith, the number of shares issuable upon exercise of the warrants was adjusted to be equal to 10% of
the aggregate number of common stock shares issued by the Company upon conversion of 4,142,270 shares of Series B preferred stock
(the “Preferred B Adjustment Provision”).
In connection with the IPO, pursuant to the Preferred B
Adjustment Provision variable settlement provision, the number of shares of common stock subject to the Preferred B Placement Warrants
settled, resulting in an additional 49,528 shares of common stock.
Convertible Note Placement Warrants
In connection with the Convertible Notes, the
Company issued 10,000 and 214,050 warrants to purchase common stock, to a noteholder and its brokers, respectively. The warrants have
a five-year life and are initially exercisable into common stock at $2.97 per share with the warrants ultimately being exercisable into
common stock at the final Conversion Price of the Convertible Notes. When the Convertible Notes converted at the IPO date as described
in Note 9, the exercise price of the warrants was adjusted to equal the Conversion Price, which is $2.57. During March 2021,
42,220 of these warrants to purchase common stock were cancelled.
Movano Inc.
Notes to Condensed Consolidated Financial Statements
For the three months and nine months ended September
30, 2021 and 2020
(Unaudited)
Underwriter Warrants
In connection with the IPO, the Company issued
the underwriter a warrant to purchase shares of common stock equal to 9.79% of the shares of common stock sold in the IPO or 956,973 shares.
The warrant is exercisable at $6.00 per share and has a 5-year term. Additionally, the underwriter has contractually agreed that it will
not sell, transfer, assign, pledge, or hypothecate this warrant or the securities underlying this warrant, nor will it engage in any hedging,
short sale, derivative, put, or call transaction that would result in the effective economic disposition of this warrant or the underlying
securities for a period of 540 days (approximately 18 months) from the IPO.
The following is a summary of the Company’s
warrant activity for the nine months ended September 30, 2021:
Warrant
Issuance
|
|
Issuance
|
|
Exercise
Price
|
|
|
Outstanding,
December 31,
2020
|
|
|
Granted
|
|
|
Exercised
|
|
|
Canceled/
Expired
|
|
|
Variable
Settlement Provision Adjustment
|
|
|
Outstanding,
September 30,
2021
|
|
|
Expiration
|
Preferred
A Placement Warrants
|
|
March and April 2018
and August 2019
|
|
$
|
1.40
|
|
|
|
242,847
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
50,195
|
|
|
|
293,042
|
|
|
March and April 2023
|
Preferred
A Lead Investor Warrants
|
|
February 2021
|
|
$
|
0.0125
|
|
|
|
—
|
|
|
|
52,500
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
52,500
|
|
|
March 2023
|
Preferred
B Placement Warrants
|
|
April 2019
|
|
$
|
2.10
|
|
|
|
414,270
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
49,528
|
|
|
|
463,798
|
|
|
April 2024
|
Convertible
Notes Placement Warrants
|
|
August 2020
|
|
$
|
2.57
|
|
|
|
214,050
|
|
|
|
—
|
|
|
|
—
|
|
|
|
(42,220
|
)
|
|
|
—
|
|
|
|
171,830
|
|
|
August 2025
|
Underwriter
Warrants
|
|
March 2021
|
|
$
|
6.00
|
|
|
|
—
|
|
|
|
956,973
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
956,973
|
|
|
March 2026
|
|
|
|
|
|
|
|
|
|
871,167
|
|
|
|
1,009,473
|
|
|
|
—
|
|
|
|
(42,220
|
)
|
|
|
99,723
|
|
|
|
1,938,143
|
|
|
|
Warrants Classified as Liabilities
Preferred A Placement Warrants and Preferred
B Placement Warrants
The Preferred A Placement Warrants and Preferred B
Placement Warrants were initially classified as a derivative liability because their variable terms did not qualify these as being indexed
to the Company’s own common stock and will be measured at fair value on a recurring basis.
As a result of the conversion of the Preferred
Stock into common stock in connection with the IPO, and the related impact of the Preferred A Adjustment Provision and the Preferred B
Adjustment Provision, the number of warrant shares that are convertible is no longer variable. Accordingly, the Preferred A Placement
Warrants and Preferred B Placement Warrants were determined to be indexed to the Company’s own common stock and will no longer
be measured at fair value on a recurring basis. Instead, the Preferred A Placement Warrants and the Preferred B Placement Warrants
were determined to be equity instruments, and the liability was recorded at fair value with the change in fair value recorded in the condensed
consolidated statement of operations and comprehensive loss and reclassified to additional paid-in capital at their estimated fair value
at the IPO date.
Convertible Notes Placement Warrants
The Convertible Notes Placement Warrants were
classified as a derivative liability because the exercise price was variable, thus these did not qualify as being indexed to the Company’s
own common stock and were measured at fair value on a recurring basis.
As a result of the conversion of the Convertible
Notes into common stock in connection with the IPO, the exercise price is no longer variable. Accordingly, the Convertible Notes Placement
Warrants were determined to be indexed to the Company’s own common stock and will no longer be measured at fair value on a recurring
basis. Instead the Convertible Notes Placement Warrants were determined to be equity instruments, and the liability was recorded at fair
value with the change in fair value recorded in the condensed consolidated statement of operations and comprehensive loss and reclassified
to additional paid-in capital at their estimated fair value at the IPO date.
Movano Inc.
Notes to Condensed Consolidated Financial Statements
For the three months and nine months ended September
30, 2021 and 2020
(Unaudited)
Estimated Fair Value of Outstanding Warrants
Classified as Liabilities
The estimated fair value of outstanding warrants
classified as liabilities is determined at each balance sheet date. Any decrease or increase in the estimated fair value of the warrant
liability since the most recent balance sheet date is recorded in the condensed consolidated statements of operations and comprehensive
loss as a change in fair value of warrant liability.
There were no warrants classified as liabilities
outstanding as of September 30, 2021.
The changes in fair value of the outstanding warrants
classified as liabilities for the nine months ended September 30, 2021 were as follows (in thousands):
Warrant Issuance
|
|
Warrant liability,
December 31,
2020
|
|
|
Fair value of
warrants granted
|
|
|
Fair value of
warrants exercised
|
|
|
Change in fair
value of warrants
|
|
|
Reclassified to
additional paid-in
capital
|
|
|
Warrant liability,
September 30,
2021
|
|
Preferred A Placement Warrants
|
|
$
|
518
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
575
|
|
|
$
|
(1,093
|
)
|
|
$
|
—
|
|
Preferred B Placement Warrants
|
|
|
708
|
|
|
|
—
|
|
|
|
—
|
|
|
|
800
|
|
|
|
(1,508
|
)
|
|
|
—
|
|
Convertible Notes Placement Warrants
|
|
|
323
|
|
|
|
—
|
|
|
|
—
|
|
|
|
206
|
|
|
|
(529
|
)
|
|
|
—
|
|
|
|
$
|
1,549
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
1,581
|
|
|
$
|
(3,130
|
)
|
|
$
|
—
|
|
The changes in fair value of the warrant liability for the nine months
ended September 30, 2020 were as follows (in thousands):
Warrant Issuance
|
|
Warrant liability,
December 31,
2019
|
|
|
Fair value of
warrants granted
|
|
|
Fair value of
warrants exercised
|
|
|
Change in fair
value of warrants
|
|
|
Warrant liability,
September 30,
2020
|
|
Preferred A Placement Warrants
|
|
$
|
12
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
(1
|
)
|
|
$
|
11
|
|
Preferred B Placement Warrants
|
|
|
20
|
|
|
|
—
|
|
|
|
—
|
|
|
|
(7
|
)
|
|
|
13
|
|
Convertible Notes Placement Warrants
|
|
|
—
|
|
|
|
6
|
|
|
|
—
|
|
|
|
—
|
|
|
|
6
|
|
|
|
$
|
32
|
|
|
$
|
6
|
|
|
$
|
—
|
|
|
$
|
(8
|
)
|
|
$
|
30
|
|
The fair values of the outstanding warrants accounted
for as liabilities at the IPO date are calculated using the Black-Scholes option pricing model with the following assumptions:
|
|
Black-Scholes Fair Value Assumptions at IPO Date
|
|
Warrant Issuance
|
|
Dividend
Yield
|
|
|
Expected
Volatility
|
|
|
Risk-Free
Interest
Rate
|
|
|
Expected
Life
|
|
Preferred A Placement Warrants
|
|
|
–
|
%
|
|
|
59.21
|
%
|
|
|
0.14
|
%
|
|
|
2.0 years
|
|
Preferred B Placement Warrants
|
|
|
–
|
%
|
|
|
58.51
|
%
|
|
|
0.30
|
%
|
|
|
3.0 years
|
|
Convertible Note Placement Warrants
|
|
|
–
|
%
|
|
|
52.28
|
%
|
|
|
0.82
|
%
|
|
|
4.4 years
|
|
Upon the conversion of the redeemable convertible
preferred stock and the Convertible Notes into common stock at the IPO date, the estimated fair value of the outstanding warrants accounted
for as liabilities of $3.1 million was reclassified to additional paid-in capital.
The fair values of the outstanding warrants accounted
for as liabilities at December 31, 2020 are calculated using the Black-Scholes option pricing model with the following assumptions:
|
|
Black-Scholes Fair Value Assumptions - December 31, 2020
|
|
Warrant Issuance
|
|
Dividend
Yield
|
|
|
Expected
Volatility
|
|
|
Risk-Free
Interest
Rate
|
|
|
Expected
Life
|
|
Preferred A Placement Warrants
|
|
|
–
|
%
|
|
|
67.75
|
%
|
|
|
0.13
|
%
|
|
2.2 years
|
|
Preferred B Placement Warrants
|
|
|
–
|
%
|
|
|
55.76
|
%
|
|
|
0.17
|
%
|
|
3.3 years
|
|
Convertible Note Placement Warrants
|
|
|
–
|
%
|
|
|
52.93
|
%
|
|
|
0.36
|
%
|
|
4.7 years
|
|
Movano Inc.
Notes to Condensed Consolidated Financial Statements
For the three months and nine months ended September
30, 2021 and 2020
(Unaudited)
The fair values of the outstanding warrants accounted
for as liabilities at September 30, 2020 are calculated using the Black-Scholes option pricing model with the following assumptions:
|
|
Black-Scholes Fair Value Assumptions - September 30, 2020
|
Warrant Issuance
|
|
Dividend
Yield
|
|
|
Expected
Volatility
|
|
|
Risk-Free
Interest
Rate
|
|
|
Expected Life
|
Preferred A Placement Warrants
|
|
|
–
|
%
|
|
|
53.73
|
%
|
|
|
0.15
|
%
|
|
2.5 years
|
Preferred B Placement Warrants
|
|
|
–
|
%
|
|
|
49.39
|
%
|
|
|
0.22
|
%
|
|
3.5 years
|
Convertible Note Placement Warrants
|
|
|
–
|
%
|
|
|
47.65
|
%
|
|
|
0.31
|
%
|
|
4.9 years
|
Warrants Classified as Equity
Certain warrants are classified as equity instruments
since they do not meet the characteristics of a liability or a derivative and are recorded at fair value on the date of issuance using
the Black-Scholes option pricing model with the following assumptions. The fair value as determined at the issuance date is recorded as
an issuance cost of the related stock. Those warrants and the assumptions used to calculate the fair value at issuance are as follows
for the warrants issued during the nine months ended September 30, 2021. There were no warrants issued during the three months ended
September 30, 2021, nor during the three and nine months ended September 30, 2020.
|
|
Black-Scholes Fair Value Assumptions
|
Warrant Issuance
|
|
Issuance
Date
|
|
Fair
Value
|
|
|
Dividend
Yield
|
|
|
Expected
Volatility
|
|
|
Risk-Free
Interest
Rate
|
|
|
Expected
Life
|
Underwriter Warrants
|
|
March 2021
|
|
$
|
2,349
|
|
|
|
–
|
%
|
|
|
52.58
|
%
|
|
|
0.82
|
%
|
|
5.0 years
|
Note
12 – Stock-based Compensation
2019 Equity Incentive Plan
Effective as of November 18, 2019, the Company
adopted the 2019 Omnibus Incentive Plan (“2019 Plan”) administered by the Board. The 2019 Plan provides for
the issuance of incentive stock options, non-statutory stock options, and restricted stock awards, for the purchase of up to a total of
4,000,000 shares of the Company’s common stock to employees, directors, and consultants and replaces the previous plan. The Board
or a committee of the Board has the authority to determine the amount, type, and terms of each award. The options granted under the 2019 Plan
generally have a contractual term of ten years and a vesting term of four years with a one-year cliff. The exercise price for options
granted under the 2019 Plan must generally be at least equal to 100% of the fair value of the Company’s common stock at the
date of grant, as determined by the Board. The incentive stock options granted under the 2019 Plan to 10% or greater stockholders
must have an exercise price at least equal to 110% of the fair value of the Company’s common stock at the date of grant, as determined
by the Board, and have a contractual term of ten years.
On September 30, 2020, the Board approved
an increase in the aggregate number of shares of common stock that may be issued pursuant to the 2019 Plan from 4,000,000 to 4,500,000.
On December 7, 2020, the Board approved an
increase in the aggregate number of shares of common stock that may be issued pursuant to the 2019 Plan from 4,500,000 to 6,000,000.
In connection with the closing of the IPO, effective
as of March 25, 2021 the 2019 Plan was amended and restated as a result of which the aggregate number of shares of common stock
that may be issued pursuant to the 2019 Plan was increased from 6,000,000 to 7,400,000.
As of September 30, 2021, the Company had
830,322 shares available for future grant under the 2019 Plan.
Movano Inc.
Notes to Condensed Consolidated Financial Statements
For the three months and nine months ended September
30, 2021 and 2020
(Unaudited)
Stock Options
Stock option activity for the nine months ended
September 30, 2021 was as follows (in thousands, except share, per share, and remaining life data):
|
|
Number of Options
|
|
|
Weighted Average Exercise Price
|
|
|
Weighted Average Remaining Life
|
|
Intrinsic Value
|
|
Outstanding at December 31, 2020
|
|
|
3,188,011
|
|
|
$
|
0.66
|
|
|
9.0 years
|
|
$
|
8,155
|
|
Granted
|
|
|
1,970,000
|
|
|
$
|
3.75
|
|
|
|
|
|
|
|
Exercised
|
|
|
(134,541
|
)
|
|
$
|
0.56
|
|
|
|
|
|
|
|
Cancelled
|
|
|
(145,833
|
)
|
|
$
|
0.59
|
|
|
|
|
|
|
|
Outstanding at September 30, 2021
|
|
|
4,877,637
|
|
|
$
|
1.91
|
|
|
8.7 years
|
|
$
|
8,368
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercisable as of September 30, 2021
|
|
|
1,902,685
|
|
|
$
|
0.52
|
|
|
8.1 years
|
|
$
|
5,566
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Vested and expected to vest as of September 30, 2021
|
|
|
4,827,437
|
|
|
$
|
1.93
|
|
|
8.7 years
|
|
$
|
8,214
|
|
The weighted-average grant date fair value of
options granted during the nine months ended September 30, 2021 and 2020 was $2.76 and $0.31. During the nine months ended September 30,
2021 and 2020, 134,531 and no options were exercised for proceeds of $76,000 and $0, respectively. The fair value of the 598,988 and 688,155
options that vested during the nine months ended September 30, 2021 and 2020 was approximately $0.4 million and $0.2 million,
respectively.
The Company estimated the fair value of stock
options using the Black-Scholes option pricing model. The fair value of the stock options was estimated using the following weighted average
assumptions for the nine months ended September 30, 2021 and 2020.
|
|
Nine Months Ended
September 30,
|
|
|
|
2021
|
|
|
2020
|
|
|
|
|
|
|
|
|
Dividend yield
|
|
|
–
|
%
|
|
|
–
|
%
|
Expected volatility
|
|
|
67.54
|
%
|
|
|
67.92
|
%
|
Risk-free interest rate
|
|
|
0.76
|
%
|
|
|
0.46
|
%
|
Expected life
|
|
|
6.06 years
|
|
|
|
5.77 years
|
|
Dividend Rate—The expected dividend
rate was assumed to be zero, as the Company had not previously paid dividends on common stock and has no current plans to do so.
Expected Volatility—The expected
volatility was derived from the historical stock volatilities of several public companies within the Company’s industry that the
Company considers to be comparable to the business over a period equivalent to the expected term of the stock option grants.
Risk-Free Interest Rate—The risk-free
interest rate is based on the interest yield in effect at the date of grant for zero coupon U.S. Treasury notes with maturities approximately
equal to the option’s expected term.
Expected Term—The expected term represents
the period that the Company’s stock options are expected to be outstanding. The expected term of option grants that are considered
to be “plain vanilla” are determined using the simplified method. The simplified method deems the term to be the average of
the time-to-vesting and the contractual life of the options. For other option grants not considered to be “plain vanilla,”
the Company determined the expected term to be the contractual life of the options.
Forfeiture Rate—The Company made
the one-time policy election to recognize forfeitures when they occur.
Movano Inc.
Notes to Condensed Consolidated Financial Statements
For the three months and nine months ended September
30, 2021 and 2020
(Unaudited)
The Company has recorded stock-based compensation
expense for the three and nine months ended September 30, 2021 and 2020 related to the issuance of stock option awards to employees
and nonemployees in the condensed consolidated statement of operations and comprehensive loss as follows:
|
|
Three Months Ended
September 30,
|
|
|
Nine Months Ended
September 30,
|
|
|
|
2021
|
|
|
2020
|
|
|
2021
|
|
|
2020
|
|
Research and development
|
|
$
|
217
|
|
|
$
|
15
|
|
|
$
|
467
|
|
|
$
|
40
|
|
General and administrative
|
|
|
335
|
|
|
|
136
|
|
|
|
780
|
|
|
|
201
|
|
|
|
$
|
552
|
|
|
$
|
151
|
|
|
$
|
1,247
|
|
|
$
|
241
|
|
As of September 30, 2021, unamortized compensation
expense related to unvested stock options was approximately $7.0 million, which is expected to be recognized over a weighted average
period of 2.9 years.
Note
13 – Commitments and Contingencies
Operating Leases
As of September 30, 2021, the Company had
one office lease. Another lease, for facility space in Dublin, California expired in September 2021.
On April 15, 2021, the Company executed a
lease agreement for corporate office space. The lease commenced on May 14, 2021 when the improvements were completed by the landlord
and the Company had access to the facility. The lease term is 40 months, and the base rent is approximately $14,000 per month for
the first twelve months, with subsequent escalation provisions for future months. The Company paid a security deposit of approximately
$47,000.
Future minimum lease payments for this new corporate
office space lease are as follows as of September 30, 2021:
Remainder of 2021
|
|
$
|
42
|
|
2022
|
|
|
173
|
|
2023
|
|
|
179
|
|
2024
|
|
|
138
|
|
Total
|
|
$
|
532
|
|
Rent expense for the three months ended September 30,
2021 and 2020 was $57,000 and $28,000, respectively. Rent expense for the nine months ended September 30, 2021 and 2020 was $105,000
and $84,000, respectively.
Litigation
From time to time, the Company may become involved
in various litigation and administrative proceedings relating to claims arising from its operations in the normal course of business.
Management is not currently aware of any matters that may have a material adverse impact on the Company’s business, financial position,
results of operations or cash flows.
Movano Inc.
Notes to Condensed Consolidated Financial Statements
For the three months and nine months ended September
30, 2021 and 2020
(Unaudited)
Indemnification
The Company enters into standard indemnification
agreements in the ordinary course of business. Pursuant to these arrangements, the Company indemnifies, holds harmless and agrees to reimburse
the indemnified parties for losses suffered or incurred by the indemnified party, in connection with any trade secret, copyright, patent
or other intellectual property infringement claim by any third party with respect to its technology. The term of these indemnification
agreements is generally perpetual after the execution of the agreement. The maximum potential amount of future payments the Company could
be required to make under these agreements is not determinable because it involves claims that may be made against the Company in the
future, but have not yet been made. The Company has not incurred costs to defend lawsuits or settle claims related to these indemnification
agreements.
The Company has entered into indemnification agreements
with its directors and officers that may require the Company to indemnify its directors and officers against liabilities that may arise
by reason of their status or service as directors or officers, other than liabilities arising from willful misconduct of the individual.
No amounts associated with such indemnifications
have been recorded as of September 30, 2021.
Note
14 – NET LOSS PER SHARE ATTRIBUTABLE TO COMMON STOCKHOLDERS
The following table computes the computation of
the basic and diluted net loss per share attributable to common stockholders during the three and nine months ended September 30,
2021 and 2020 is as follows (in thousands, except share and per share data):
|
|
Three Months Ended
September 30,
|
|
|
Nine Months Ended
September 30,
|
|
|
|
2021
|
|
|
2020
|
|
|
2021
|
|
|
2020
|
|
Numerator:
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss
|
|
$
|
(5,173
|
)
|
|
$
|
(3,341
|
)
|
|
$
|
(15,468
|
)
|
|
$
|
(8,105
|
)
|
Accretion and dividends on redeemable convertible preferred stock
|
|
|
-
|
|
|
|
(2,322
|
)
|
|
|
(2,489
|
)
|
|
|
(6,396
|
)
|
Net loss attributable to common stockholders
|
|
$
|
(5,173
|
)
|
|
$
|
(5,663
|
)
|
|
$
|
(17,957
|
)
|
|
$
|
(14,501
|
)
|
Denominator:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted-average common shares outstanding
|
|
|
32,268,890
|
|
|
|
3,029,765
|
|
|
|
24,200,475
|
|
|
|
2,777,510
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss per share attributable to common stockholders, basic and diluted
|
|
$
|
(0.16
|
)
|
|
$
|
(1.87
|
)
|
|
$
|
(0.74
|
)
|
|
$
|
(5.22
|
)
|
The potential shares of common stock that were
excluded from the computation of diluted net loss per share attributable to common stockholders for the three and nine months ended September 30,
2021 and 2020 because including them would have been antidilutive are as follows:
|
|
September 30,
|
|
|
|
2021
|
|
|
2020
|
|
Shares of redeemable convertible preferred stock
|
|
|
—
|
|
|
|
7,634,572
|
|
Non-vested shares under restricted stock grants
|
|
|
336,666
|
|
|
|
1,346,667
|
|
Shares related to convertible promissory notes
|
|
|
—
|
|
|
|
1,399,254
|
|
Shares subject to options to purchase common stock
|
|
|
4,877,637
|
|
|
|
3,897,478
|
|
Shares subject to warrants to purchase common stock
|
|
|
1,938,143
|
|
|
|
1,174,168
|
|
Total
|
|
|
7,152,447
|
|
|
|
15,452,139
|
|
For the three and nine months ended September 30,
2021 and 2020, performance based option awards for 50,200 shares of common stock, respectively, are not included in in the table above
or considered in the calculation of diluted earnings per share until the performance conditions of the option award are considered probable
by the Company.
Note
15 – Subsequent Events
Management of the Company evaluated events that
have occurred after the balance sheet dates through the date these condensed consolidated financial statements were issued. Based upon
the review, management did not identify any recognized or non-recognized subsequent events that would have required
adjustment or disclosure in the condensed consolidated financial statements.